Drug-discovery company developing small-molecule drugs for oncology and neurology.
| Date | Round | Amount |
|---|---|---|
| May 2023 | Funding round Cambridge biotech PharmEnable raised $7.5M pre-Series A led by MP Healthcare Venture Management. | $7.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.